Literature DB >> 22100032

Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C.

Luca Valenti, Massimo Colombo, Silvia Fargion.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22100032     DOI： 10.1016/j.jhep.2011.04.032

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  7 in total

1.  The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.

Authors:  Paul J Clark; Alexander J Thompson; Qianqian Zhu; David M Vock; Mingfu Zhu; Keyur Patel; Stephen A Harrison; Susanna Naggie; Dongliang Ge; Hans L Tillmann; Thomas J Urban; Kevin Shianna; Jacques Fellay; Zachary Goodman; Stephanie Noviello; Lisa D Pedicone; Nezam Afdhal; Mark Sulkowski; Janice K Albrecht; David B Goldstein; John G McHutchison; Andrew J Muir
Journal:  Dig Dis Sci       Date:  2012-04-29       Impact factor: 3.199

2.  Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.

Authors:  Kohichiroh Yasui; Takahisa Kawaguchi; Toshihide Shima; Hironori Mitsuyoshi; Kojiro Seki; Rei Sendo; Masayuki Mizuno; Yoshito Itoh; Fumihiko Matsuda; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2014-11-26       Impact factor: 7.527

Review 3.  Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes.

Authors:  Tracey G Simon; Adeel A Butt
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 4.  PNPLA3 I148M polymorphism and progressive liver disease.

Authors:  Paola Dongiovanni; Benedetta Donati; Roberta Fares; Rosa Lombardi; Rosellina Margherita Mancina; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

5.  PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations.

Authors:  Elena Larrieta-Carrasco; Victor Acuña-Alonzo; Rafael Velázquez-Cruz; Rodrigo Barquera-Lozano; Paola León-Mimila; Hugo Villamil-Ramírez; Marta Menjivar; Sandra Romero-Hidalgo; Nahúm Méndez-Sánchez; Vanessa Cárdenas; Manuel Bañuelos-Moreno; Yvonne N Flores; Manuel Quiterio; Jorge Salmerón; Fausto Sánchez-Muñoz; Teresa Villarreal-Molina; Carlos A Aguilar-Salinas; Samuel Canizales-Quinteros
Journal:  Mol Biol Rep       Date:  2014-04-02       Impact factor: 2.316

Review 6.  Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis.

Authors:  Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal:  Biomed Res Int       Date:  2015-07-27       Impact factor: 3.411

7.  Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

Authors:  Paola Dongiovanni; Quentin M Anstee; Luca Valenti
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.